<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 3.2//EN">
<HTML>
<HEAD>
<META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=iso-8859-1">
<META NAME="Generator" CONTENT="MS Exchange Server version 6.5.7654.12">
<TITLE>torsion NCS and SA</TITLE>
</HEAD>
<BODY>
<!-- Converted from text/rtf format -->
<P DIR=LTR><SPAN LANG="de"></SPAN><SPAN LANG="en-us"><FONT FACE="Calibri">Dear all,</FONT></SPAN></P>
<P DIR=LTR><SPAN LANG="en-us"><FONT FACE="Calibri">Is it safe to use torsion NCS</FONT></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"> <FONT FACE="Calibri">(</FONT></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"><FONT FACE="Calibri">refinement</FONT></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"><FONT FACE="Calibri">.ncs.type=</FONT></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"><FONT FACE="Calibri">”</FONT></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"><FONT FACE="Calibri">torsion</FONT></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"><FONT FACE="Calibri">”</FONT></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"><FONT FACE="Calibri">) and torsion SA (</FONT></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"><FONT FACE="Calibri">refinement</FONT></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"><FONT FACE="Calibri">.</FONT></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"><FONT FACE="Calibri">main.</FONT></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"><FONT FACE="Calibri">simulated_annealing_torsion</FONT></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"><FONT FACE="Calibri">=</FONT></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"> <FONT FACE="Calibri">“</FONT></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"><FONT FACE="Calibri">true</FONT></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"><FONT FACE="Calibri">”</FONT></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"><FONT FACE="Calibri">)</FONT></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"> <FONT FACE="Calibri">as a default?</FONT></SPAN></P>
<P DIR=LTR><SPAN LANG="de"><FONT FACE="Calibri">Thanks for advice,</FONT></SPAN></P>
<P DIR=LTR><SPAN LANG="de"><FONT FACE="Calibri">Dirk</FONT></SPAN><SPAN LANG="de"></SPAN></P>
<P DIR=LTR><SPAN LANG="de"></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"><FONT SIZE=2 FACE="Calibri">---</FONT></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"></SPAN></P>
<P DIR=LTR><SPAN LANG="en-us"><FONT SIZE=2 FACE="Arial">Dr. Dirk Reinert</FONT></SPAN></P>
<P DIR=LTR><SPAN LANG="en-us"><FONT SIZE=2 FACE="Arial">Boehringer Ingelheim Pharma GmbH &</FONT> <FONT SIZE=2 FACE="Arial">Co.</FONT></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"></SPAN><SPAN LANG="en-us"> <FONT SIZE=2 FACE="Arial">KG</FONT></SPAN></P>
<P DIR=LTR><SPAN LANG="en-us"><FONT SIZE=2 FACE="Arial">Dept. Lead Identific. and Optim. Sup. Ge</FONT></SPAN></P>
<P DIR=LTR><SPAN LANG="en-us"><FONT SIZE=2 FACE="Arial">Tel.: +49 (7351) 54-97892</FONT></SPAN></P>
<P DIR=LTR><SPAN LANG="en-us"><FONT SIZE=2 FACE="Arial">Fax: +49 (7351) 83-97892</FONT></SPAN></P>
<P DIR=LTR><SPAN LANG="en-us"><FONT SIZE=2 FACE="Arial"><A HREF="mailto:dirk.reinert@boehringer-ingelheim.com">mailto:dirk.reinert@boehringer-ingelheim.com</A></FONT></SPAN></P>
<P DIR=LTR><SPAN LANG="de"></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"></SPAN><SPAN LANG="en-us"><FONT SIZE=2 FACE="Times New Roman">Boehringer Ingelheim Pharma GmbH & Co. KG, Sitz: Ingelheim am Rhein; Registergericht Mainz: HR A 22206;</FONT><FONT SIZE=2 FACE="Times New Roman"> Komplement�r Boehringer Ingelheim Deutschland GmbH;</FONT><FONT SIZE=2 FACE="Times New Roman"> Gesch�ftsf�hrung: Dr. Engelbert G�nster (Vorsitzender), Ursula Fuggis-Hahn, Ralf Gorniak, Michael K</FONT><FONT SIZE=2 FACE="Times New Roman">l</FONT><FONT SIZE=2 FACE="Times New Roman">ein, Dr. Martin Wanning; Vorsitzender des Aufsichtsrates: Prof. Dr. Dr. Andreas Barner; Sitz: Ingelheim am Rhein; Registergericht Mainz: HR B 23260</FONT></SPAN></P>
<P DIR=LTR><SPAN LANG="de"></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"></SPAN><SPAN LANG="en-us"><FONT COLOR="#0000FF" SIZE=2 FACE="Times New Roman">Diese E-Mail ist vertraulich zu behandeln. Sie kann besonderem rechtlichen Schutz unterliegen. Wenn Sie nic</FONT><FONT COLOR="#0000FF" SIZE=2 FACE="Times New Roman">ht der richtige Adressat sind, senden Sie bitte diese E-Mail an den Absender zur�ck, l�schen die eingegangene E-Mail und geben den Inhalt der E-Mail nicht weiter. Jegliche unbefugte Bearbeitung, Nutzung, Vervielf�ltigung oder Verbreitung ist verboten. / T</FONT><FONT COLOR="#0000FF" SIZE=2 FACE="Times New Roman">h</FONT><FONT COLOR="#0000FF" SIZE=2 FACE="Times New Roman">is e-mail is confidential and may also be legally privileged.</FONT></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"></SPAN><SPAN LANG="en-us"> <FONT COLOR="#0000FF" SIZE=2 FACE="Times New Roman">If you are not the intended recipient please reply to sender, delete the e-mail and do not disclose its contents to any person. Any unauthorized review, use, disclosure, copying or distribution</FONT> <FONT COLOR="#0000FF" SIZE=2 FACE="Times New Roman">is strictly prohibited.</FONT></SPAN><SPAN LANG="de"><I></I></SPAN><SPAN LANG="de"><I></I></SPAN><I><SPAN LANG="en-us"></SPAN></I></P>
<P DIR=LTR><SPAN LANG="de"></SPAN><SPAN LANG="de"></SPAN><SPAN LANG="en-us"></SPAN></P>
<P DIR=LTR><SPAN LANG="de"></SPAN><SPAN LANG="en-us"></SPAN></P>
</BODY>
</HTML>